FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Madsen Julia		 2. Date of Event Requiring Statement (MM/DD/YYYY)
7/28/2020 

 3. Issuer Name and Ticker or Trading Symbol

STERIS plc [STE]
(Last)        (First)        (Middle)

C/O 70 SIR ROGER'S QUAY		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Senior VP, Life Sciences /
(Street)

DUBLIN, L2 2      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Ordinary Shares 3245 (1)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)  (2)5/31/2023 Ordinary Shares 1100 $45.34 D  
Employee Stock Option (right to buy)  (2)5/30/2024 Ordinary Shares 800 $53.52 D  
Employee Stock Option (right to buy)  (2)5/28/2025 Ordinary Shares 700 $66.15 D  
Employee Stock Option (right to buy)  (2)6/1/2026 Ordinary Shares 2700 $69.72 D  
Employee Stock Option (right to buy)  (3)5/30/2027 Ordinary Shares 3252 $77.07 D  
Employee Stock Option (right to buy)  (4)5/31/2028 Ordinary Shares 2872 $114.22 D  
Employee Stock Option (right to buy)  (5)5/31/2029 Ordinary Shares 2136 $147.05 D  
Employee Stock Option (right to buy)  (6)6/1/2030 Ordinary Shares 2984 $182.22 D  
Explanation of Responses:
(1) 1,318 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 123 on June 3, 2024.
(2) This option is fully vested.
(3) This option becomes exercisable as follows: 813 May 30, 2018; 813 on May 30, 2019; 813 on May 30, 2020; and 813 on June 1, 2021.
(4) This option becomes exercisable as follows: 718 on May 31, 2019; 718 on May 31, 2020; 718 on June 1, 2021; and 718 on May 31, 2022.
(5) This option becomes exercisable as follows: 534 on May 31, 2020; 534 on June 1, 2021; 534 on May 31, 2022; and 534 on May 31, 2023.
(6) This option becomes exercisable as follows: 746 on June 1, 2021; 746 on June 1, 2022; 746 on June 1, 2023; and 746 on June 3, 2024.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Madsen Julia
C/O 70 SIR ROGER'S QUAY
DUBLIN, L2 2

Senior VP, Life Sciences
Signatures
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney8/3/2020
**Signature of Reporting PersonDate
STERIS (NYSE:STE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more STERIS Charts.
STERIS (NYSE:STE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more STERIS Charts.